Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein
Abstract The CR3022 antibody, selected from a group of SARS-CoV-1 monoclonal antibodies for its ability to cross-react with SARS-CoV-2, has been examined for its ability to bind to the ectodomain of the SARS-CoV-2 spike glycoprotein. Using electron cryo-microscopy we show that antibody binding requires rearrangements in the S1 domain that result in dissociation of the spike.
1996 ◽
Vol 3
(4)
◽
pp. 287-295
◽
1987 ◽
Vol 164
(1)
◽
pp. 12-22
◽
Keyword(s):
1985 ◽
Vol 100
(5)
◽
pp. 1592-1600
◽
2019 ◽
Vol 8
(1)
◽
pp. 516-530
◽